Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Phase II Randomized, Blinded Study to Demonstrate the Effectiveness of Jobelyn for the Treatment of Breast Cancer Patients.

NCT01936064 is registered in ClinicalTrials.gov with Lagos State University as lead sponsor.

NCT NCT01936064
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01936064 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Phase II Randomized, Blinded Study to Demonstrate the Effectiveness of Jobelyn for the Treatment of Breast Cancer Patients.
Lead sponsor
Lagos State University
Phase
Phase 1/2
Overall status
Unknown status
Start date
October 31, 2016
Completion date
January 31, 2018
Enrollment
60 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

haematological abnormality